Hick and Radhakrishnan on Religious Diversity: Back to the Kantian Noumenon

We shall examine some conceptual tensions in Hick’s ‘pluralism’ in the light of S. Radhakrishnan’s reformulation of classical Advaita. Hick himself often quoted Radhakrishnan’s translations from the Hindu scriptures in support of his own claims about divine ineffability, transformative experience and religious pluralism. However, while Hick developed these themes partly through an adaptation of Kantian epistemology, Radhakrishnan derived them ultimately from Śaṁkara (c.800 CE), and these two distinctive points of origin lead to somewhat different types of reconstruction of the diversity of world religions. Our argument will highlight the point that Radhakrishnan is not a ‘pluralist’ in terms of Hick’s understanding of the Real. The Advaitin ultimate, while it too like Hick’s Real cannot be encapsulated by human categories, is, however, not strongly ineffable, because some substantive descriptions, according to the Advaitic tradition, are more accurate than others. Our comparative analysis will reveal that they differ because they are located in two somewhat divergent metaphysical schemes. In turn, we will be able to revisit, through this dialogue between Hick and Radhakrishnan, the intensely vexed question of whether Hick’s version of pluralism is in fact a form of covert exclusivism.This is the author accepted manuscript. The final version is available from Springer via http://dx.doi.org/10.1007/s11841-015-0459-

Calling in Today\u27s World: Multifaith Perspectives

What does a Buddhist think about calling? Does a Jew have a similar sense of vocation as a Christian? Do people besides Christians have a sense of calling? While most religious traditions do not share the same notion of calling as Christians, they do, in fact, have surprisingly similar concepts and practices. In a new book, Calling in Today\u27s World: Voices from Eight Faith Perspectives, experts representing Jewish, Islamic, Hindu, Buddhist, Confucian, Daoist, secular humanist, and Catholic and Protestant Christian traditions explore how callings are experienced and lived within their communities of faith. This ground-breaking volume offers key texts, stories, persons, concepts, and discernment practices that exemplify each tradition\u27s view of vocation as well as how modern life poses both difficulties and opportunities for living out a sense of calling. As the United States becomes more religiously diverse, members of faith communities meet every day in college classes, work places, neighborhoods, volunteer organizations, and efforts for social change. If people of faith want to live and work together for the common good, understanding each other\u27s values and beliefs is imperative. Learning how others experience a sense of calling and live with meaning and purpose can enliven and deepen connections across communities. The three panelists for this program - representing the Jewish, Hindu, and Buddhist traditions - are contributors to Calling in Today\u27s World, and the moderator - a Christian - is one of the book\u27s editors

The manufacture of hope : religion, eschatology and the culture of optimism

This article builds on earlier research, which concludes that societies cannot sustain themselves without cultures of optimism. These cultures are reproduced by a complex of ‘optimism promoters’, all of which can be seen to be engaged in a kind of unstated or ‘implicit’ cultural policy, with the production of optimism as one of its goals. The institution of religion is part of this complex. Its role in the production of optimism is the focus of this article, with particular reference to soteriology (theories of salvation) and eschatology. From a ‘detached’ and ‘functionalist’ perspective, it analyses how religions manufacture hope through (1) the production of meaning; (2) through their models of divine justice; and (3) through theories of ultimate destiny. These matters are discussed in relation to Hinduism, Buddhism, Christianity and Islam. The article concludes that the optimisms of religion are of a quite different order from those promoted by other institutions

Racial, Ethnic, and Language-Based Inequities in Inpatient Opioid Prescribing by Diagnosis from Internal Medicine Services, a Retrospective Cohort Study

Introduction. Opioid administration is extremely common in the inpatient setting, yet we do not know how the administration of opioids varies across different medical conditions and patient characteristics on internal medicine services. Our goal was to assess racial, ethnic, and language-based inequities in opioid prescribing practices for patients admitted to internal medicine services. Methods. We conducted a retrospective cohort study of all adult patients admitted to internal medicine services from 2013 to 2021 and identified subcohorts of patients treated for the six most frequent primary hospital conditions (pneumonia, sepsis, cellulitis, gastrointestinal bleed, pyelonephritis/urinary tract infection, and respiratory disease) and three select conditions typically associated with pain (abdominal pain, acute back pain, and pancreatitis). We conducted a negative binomial regression analysis to determine how average administered daily opioids, measured as morphine milligram equivalents (MMEs), were associated with race, ethnicity, and language, while adjusting for additional patient demographics, hospitalization characteristics, medical comorbidities, prior opioid therapy, and substance use disorders. Results. The study cohort included 61,831 patient hospitalizations. In adjusted models, we found that patients with limited English proficiency received significantly fewer opioids (66 MMEs, 95% CI: 52, 80) compared to English-speaking patients (101 MMEs, 95% CI: 91, 111). Asian (59 MMEs, 95% CI: 51, 66), Latinx (89 MMEs, 95% CI: 79, 100), and multi-race/ethnicity patients (81 MMEs, 95% CI: 65, 97) received significantly fewer opioids compared to white patients (103 MMEs, 95% CI: 94, 112). American Indian/Alaska Native (227 MMEs, 95% CI: 110, 344) patients received significantly more opioids. Significant inequities were also identified across race, ethnicity, and language groups when analyses were conducted within the subcohorts. Most notably, Asian and Latinx patients received significantly fewer MMEs and American Indian/Alaska Native patients received significantly more MMEs compared to white patients for the top six most frequent conditions. Most patients from minority groups also received fewer MMEs compared to white patients for three select pain conditions. Discussion. There are notable inequities in opioid prescribing based on patient race, ethnicity, and language status for those admitted to inpatient internal medicine services across all conditions and in the subcohorts of the six most frequent hospital conditions and three pain-associated conditions. This represents an institutional and societal opportunity for quality improvement initiatives to promote equitable pain management

Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: an ecological study.

BACKGROUND: The influenza A (H1N1) pandemic swept across the globe from April 2009 to August 2010 affecting millions. Many WHO Member States relied on antiviral drugs, specifically neuraminidase inhibitors (NAIs) oseltamivir and zanamivir, to treat influenza patients in critical condition. Such drugs have been found to be effective in reducing severity and duration of influenza illness, and likely reduced morbidity during the pandemic. However, it is less clear whether NAIs used during the pandemic reduced H1N1 mortality. METHODS: Country-level data on supply of oseltamivir and zanamivir were used to predict H1N1 mortality (per 100,000 people) from July 2009 to August 2010 in forty-two WHO Member States. Poisson regression was used to model the association between NAI supply and H1N1 mortality, with adjustment for economic, demographic, and health-related confounders. RESULTS: After adjustment for potential confounders, each 10% increase in kilograms of oseltamivir, per 100,000 people, was associated with a 1.6% reduction in H1N1 mortality over the pandemic period (relative rate (RR) = 0.84 per log increase in oseltamivir supply). While the supply of zanamivir was considerably less than that of oseltamivir in each Member State, each 10% increase in kilogram of active zanamivir, per 100,000, was associated with a 0.3% reduction in H1N1 mortality (RR = 0.97 per log increase). CONCLUSION: While there are limitations to the ecologic nature of these data, this analysis offers evidence of a protective relationship between antiviral drug supply and influenza mortality and supports a role for influenza antiviral use in future pandemics

Median total and monthly estimates of influenza A(H1N1) mortality and kilograms of oseltamivir and zanamivir by World Health Organization region.

<p>Median total and monthly estimates of influenza A(H1N1) mortality and kilograms of oseltamivir and zanamivir by World Health Organization region.</p

Health, health-related, and socioeconomic indicators (references noted).

<p>Health, health-related, and socioeconomic indicators (references noted).</p

World Health Organization Member States included in analysis (shaded).

<p>World Health Organization Member States included in analysis (shaded).</p

Fitted univariate poisson regression line and observed values for total influenza A (H1N1) mortality, per 100,000 people, by total oseltamivir supply, per 100,000, from April 2009 to August 2010, with corresponding 95% confidence intervals.

<p>Fitted univariate poisson regression line and observed values for total influenza A (H1N1) mortality, per 100,000 people, by total oseltamivir supply, per 100,000, from April 2009 to August 2010, with corresponding 95% confidence intervals.</p